Yvonne Puplampu-Dove

Aptamer-Targeted Attenuation of IL-2 Signaling in CD8+ T Cells Enhances Antitumor Immunity.

E. Gilboa, A. Berezhnoy, Anugraha Rajagopalan, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Immunomodulation of T- and NK-cell Responses by a Bispecific Antibody Targeting CD28 Homolog and PD-L1

Des C. Jones, G. Bhat, Taeil Kim, 2021, Cancer Immunology Research.

Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells.

M. Martin-Caraballo, Jennifer L. Hearne, Y. Puplampu-Dove, 2015, European journal of pharmacology.

Potentiating tumor immunity using aptamer-targeted RNAi to render CD8+ T cells resistant to TGFβ inhibition

E. Gilboa, Anugraha Rajagopalan, T. Gefen, 2017, Oncoimmunology.

Potentiating Tumor Immunity Using Aptamer-Targeted RNAi to Render CD8+ T Cells Resistant to TGFÎ2 Inhibition

Yvonne Puplampu-Dove, 2020 .

A TIM-3 Oligonucleotide Aptamer Enhances T Cell Functions and Potentiates Tumor Immunity in Mice.

E. Gilboa, T. Gefen, I. Castro, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.